Orphazyme A/S ORPH
Set alert
Day range unavailable
52-week range unavailable
- Open
- —
- Prev close
- 0.00
- Mkt cap
- 37.27M
- Vol
- 0
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- —
- High
- —
- Forward P/E
- -0.53
- Beta
- 0.80
- Short ratio
- 0.78
- Inst. own
- 3.80%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 1.39
- 200-d avg
- 3.45
- 1y target
- 1.00
News
3 years ago globenewswire.com
Orphazyme Announces Publication of 2022 Financial Results and Annual Report
Company announcement
4 years ago globenewswire.com
Orphazyme reports financial results in Interim Report First Half 2022
Company announcement Orphazyme A/S No. 36/2022 www.orphazyme.com Company Registration No. 32266355
4 years ago globenewswire.com
Orphazyme Announces Publication of 2021 Financial Results and Annual Report
Orphazyme A/SCompany announcement No. 30/2022 Annual reportwww.orphazyme.com Company Registration No. 32266355
4 years ago globenewswire.com
Orphazyme completes sale of substantially all of its assets and business activities to KemPharm
Orphazyme A/SCompany announcement No. 29/2022 Inside information www.orphazyme.com Company Registration No. 32266355
4 years ago globenewswire.com
Orphazyme A/S under In-Court-Restructuring to sell substantially all of its assets and business activities to KemPharm, Inc.
Orphazyme A/S in restructuring Company announcement No. 24/2022Inside information www.orphazyme.com Company Registration No. 32266355
4 years ago globenewswire.com
Orphazyme announces update on in-court restructuring proceedings
Orphazyme A/S in restructuring Company announcement No. 23/2022Inside information www.orphazyme.com Company Registration No. 32266355
4 years ago benzinga.com
Orphazyme Withdraws European Application For Arimoclomol, Initiates Delisting Of Its ADSs
Orphazyme A/S (NASDAQ: ORPH) has decided to withdraw its European Marketing Application for arimoclomol for Niemann-Pick disease Type C (NPC) ahead of a final vote and opinion by the CHMP scheduled…
4 years ago investorplace.com
Dear ORPH Stock Fans, Mark Your Calendars for March 31
After Orphazyme announced that it would withdraw the application for approval of its drug and delist its ADSs, ORPH stock is falling. The post Dear ORPH Stock Fans, Mark Your Calendars for March 31…
4 years ago globenewswire.com
Orphazyme announces withdrawal of European Marketing Authorisation Application for arimoclomol for the treatment of Niemann-Pick disease type C
Orphazyme A/S Company announcement No. 13/2022Inside information www.orphazyme.com Company Registration No. 32266355
4 years ago globenewswire.com
Orphazyme A/S has filed for voluntary delisting of ADSs
Orphazyme A/S Company announcement No. 12/2022 www.orphazyme.com Company Registration No. 32266355
4 years ago globenewswire.com
Notice of in-court restructuring proceedings of Orphazyme A/S
Orphazyme A/S Company announcement No. 11/2022 www.orphazyme.com Company Registration No. 32266355
-
4 years ago benzinga.com
Stocks That Hit 52-Week Lows On Monday
On Monday, 671 companies achieved new lows for the year.
-
4 years ago benzinga.com
95 Biggest Movers From Friday
Gainers Marygold Companies (NYSE: MGLD) shares surged 89.4% to close at $4.11 on Friday after dropping 21% on Thursday. TeraWulf Inc. (NASDAQ: WULF) gained 49.3% to close at $9.51.
-
4 years ago benzinga.com
Stocks That Hit 52-Week Lows On Friday
During Friday's session, 198 companies made new 52-week lows.
4 years ago benzinga.com
Orphazyme Calls For Court-Mediated Restructuring, Lays Off 50% Workforce
Orphazyme A/S's (NASDAQ: ORPH) board of directors has called for a court-mediated restructuring, prompting the second round of layoffs in less than a year. The in-court restructuring will determine…
-
4 years ago benzinga.com
30 Stocks Moving in Friday's Pre-Market Session
30 Stocks Moving in Friday's Pre-Market Session
4 years ago globenewswire.com
Commencement of in-court restructuring of Orphazyme A/S
Orphazyme A/S Company announcement No. 10/2022Inside information www.orphazyme.com Company Registration No. 32266355
-
4 years ago benzinga.com
Stocks That Hit 52-Week Lows On Monday
On Monday, 524 stocks hit new 52-week lows.
4 years ago globenewswire.com
Anders Vadsholt takes over as CEO of Orphazyme
Company announcement No. 08/2022 www.orphazyme.com Company Registration No. 32266355
4 years ago businesswire.com
CytRx Comments on Orphazyme's Update on European Union Regulatory Review of Arimoclomol in Niemann-Pick Disease Type C
LOS ANGELES--(BUSINESS WIRE)--CytRx Corporation (OTCQB: CYTR) (“CytRx” or the “Company”), a biopharmaceutical company focused on research and development for the oncology and neurodegenerative…
4 years ago benzinga.com
EMA's Advisory Committee Does Not Back Orphazyme's Arimoclomol Application
Orphazyme A/S (NASDAQ: ORPH) has been notified by the Committee for Medicinal Products for Human Use (CHMP) of a negative trend vote on arimoclomol application following an Oral Explanation. The…
-
4 years ago benzinga.com
32 Stocks Moving in Thursday's Pre-Market Session
Gainers Imperial Petroleum Inc. (NASDAQ: IMPP) rose 45.1% to $1.64 in pre-market trading after gaining around 41% on Wednesday.
4 years ago globenewswire.com
Orphazyme announces update on regulatory review of arimoclomol in the European Union
Orphazyme A/S Company ann ouncement No. 07/2022Inside information www.orphazyme.com Company Registration No. 32266355
4 years ago zacks.com
Orphazyme (ORPH) Up on Plans of NDA Resubmission for Rare Drug
Orphazyme (ORPH) is looking to resubmit its NDA for arimoclomol to the FDA for the treatment of Niemann-Pick disease type C in the United States. Shares rise.
4 years ago businesswire.com
CytRx Highlights Orphazyme's Update on Planned NDA Resubmission for Arimoclomol in Niemann-Pick Disease Type C
LOS ANGELES--(BUSINESS WIRE)--CytRx Corporation (OTCQB: CYTR) (“CytRx” or the “Company”), a biopharmaceutical company focused on research and development for the oncology and neurodegenerative…
4 years ago pennystocks.com
Trading Penny Stocks? Top Stock Market News for February 11th, 2022
What you need to know about trading penny stocks today The post Trading Penny Stocks? Top Stock Market News for February 11th, 2022 appeared first on Penny Stocks to Buy, Picks, News and Information…
-
5 years ago benzinga.com
Earnings Scheduled For August 24, 2021
Companies Reporting Before The Bell • 36KR Holdings (NASDAQ:KRKR) is likely to report earnings for its second quarter.
-
5 years ago benzinga.com
45 Biggest Movers From Yesterday
Gainers Entera Bio Ltd. (NASDAQ: ENTX) shares surged 44.8% to close at $6.50 on Wednesday after the company reported topline Phase 2 bone mineral density data for EB613.
-
5 years ago benzinga.com
31 Stocks Moving In Wednesday's Mid-Day Session
Gainers Entera Bio Ltd. (NASDAQ: ENTX) shares jumped 58% to $7.09 after the company reported topline Phase 2 bone mineral density data for EB613.
-
5 years ago benzinga.com
Stocks That Hit 52-Week Lows On Friday
Friday's morning session saw 17 companies set new 52-week lows.
-
5 years ago benzinga.com
Benzinga's Top Ratings Upgrades, Downgrades For March 30, 2021
Benzinga's Top Ratings Upgrades, Downgrades For March 30, 2021
-
5 years ago benzinga.com
Stocks That Hit 52-Week Highs On Wednesday
Before 10 a.m. ET on Wednesday, 375 companies hit new 52-week highs.
-
5 years ago benzinga.com
Stocks That Hit 52-Week Highs On Tuesday
Tuesday's morning session saw 269 companies set new 52-week highs.
-
5 years ago benzinga.com
Stocks That Hit 52-Week Highs On Thursday
Before 10 a.m. ET Thursday, 503 stocks hit new 52-week highs.
-
5 years ago benzinga.com
Stocks That Hit 52-Week Highs On Thursday
Before 10 a.m. ET on Thursday, 166 companies hit new 52-week highs.
-
5 years ago benzinga.com
Stocks That Hit 52-Week Highs On Wednesday
Wednesday morning saw 335 companies set new 52-week highs.
-
5 years ago benzinga.com
Stocks That Hit 52-Week Highs On Tuesday
During Tuesday's morning session, 342 companies made new 52-week highs.
-
5 years ago benzinga.com
Stocks That Hit 52-Week Highs On Friday
Friday's session saw 466 companies set new 52-week highs.